Evaluation of Prostate Specific Membrane Antigen expression in lesions diagnosed as Prostate Cancer using (2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid) (18F DCFPyL) PET/CT imaging in men undergoing Radical Prostatectomy

  • Gillatt, David (Primary Chief Investigator)
  • Chapman, Nicola (Clinical Trial Unit Staff)
  • Rai, Meenal (Clinical Trial Unit Staff)

Project: Research

Project Details

AcronymCOMPyL
StatusActive
Effective start/end date31/03/201/02/25